(Q45749192)

15 December 2017

title

Immunostimulatory CpG motifs trigger a T helper-1 immune response to human immunodeficiency virus type-1 (HIV-1) gp 160 envelope proteins (English)

1 reference

15 December 2017

author name string

L Deml

1

1 reference

15 December 2017

R Schirmbeck

2

1 reference

15 December 2017

J Reimann

3

1 reference

15 December 2017

H Wolf

4

1 reference

15 December 2017

R Wagner

5

1 reference

15 December 2017

publication date

1 March 1999

1 reference

15 December 2017

Clinical Chemistry and Laboratory Medicine

published in

1 reference

15 December 2017

volume

37

1 reference

15 December 2017

page(s)

199-204

1 reference

15 December 2017

issue

3

1 reference

15 December 2017

Antibody neutralization of HIV-1.

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Adjuvants--a classification and review of their modes of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Regulation of Isotype Immunoglobulin Production by Adjuvants in Vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

CpG motifs in bacterial DNA trigger direct B-cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

CpG-rich islands and the function of DNA methylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Immunostimulatory DNA sequences necessary for effective intradermal gene immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Increased incorporation of chimeric human immunodeficiency virus type 1 gp120 proteins into Pr55gag virus-like particles by an Epstein-Barr virus gp220/350-derived transmembrane domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Recombinant human immunodeficiency Pr55gag virus-like particles presenting chimeric envelope glycoproteins induce cytotoxic T-cells and neutralizing antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

HIV-1 gp160 as a modifier of Th1 and Th2 cytokine response: gp160 suppresses interferon-gamma and interleukin-2 production concomitantly with enhanced interleukin-4 production in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

CpG DNA, a novel immune enhancer for systemic and mucosal immunization with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

An innate immune defense mechanism based on the recognition of CpG motifs in microbial DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.1999.037

21 January 2018

Identifiers

DOI

10.1515/CCLM.1999.037

1 reference

15 December 2017

PubMed ID

10353461

1 reference

15 December 2017